Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376 · see citing works

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766 · see citing works

Neurobiology of Depression

Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217 · see citing works

Behavioural despair in rats: A new model sensitive to antidepressant treatments

Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138 · see citing works

An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

Ho Kim, S., & Mo Chung, J. (1992) · Pain · doi:10.1016/0304-3959(92)90041-9 · Cited by 3,069 · see citing works

RARE imaging: A fast imaging method for clinical MR

Hennig, J., Nauerth, A., & Friedburg, H. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030602 · Cited by 2,088 · see citing works

Animal models of neuropsychiatric disorders

Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023 · see citing works

The brain reward circuitry in mood disorders

Russo, S. J., & Nestler, E. J. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3381 · Cited by 1,870 · see citing works

Magnetic resonance imaging of perfusion using spin inversion of arterial water.

Williams, D. S., Detre, J. A., Leigh, J. S., & Koretsky, A. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.212 · Cited by 1,553 · see citing works

Sequence and expression of a metabotropic glutamate receptor

Masu, M., Tanabe, Y., Tsuchida, K., Shigemoto, R., & Nakanishi, S. (1991) · Nature · doi:10.1038/349760a0 · Cited by 1,216 · see citing works

FLASH imaging: Rapid NMR imaging using low flip-angle pulses

Haase, A., Frahm, J., Matthaei, D., Hänicke, W., & Merboldt, K. D. (2011) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2011.09.021 · Cited by 1,153 · see citing works

Towards a glutamate hypothesis of depression

Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036 · see citing works

Major depressive disorder: new clinical, neurobiological, and treatment perspectives

Kupfer, D. J., Frank, E., & Phillips, M. L. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60602-8 · Cited by 894 · see citing works

A Test for Differences between Treatment Means When Several Dose Levels are Compared with a Zero Dose Control

Williams, D. A. (1971) · Biometrics · doi:10.2307/2528930 · Cited by 780 · see citing works

The Comparison of Several Dose Levels with a Zero Dose Control

Williams, D. A. (1972) · Biometrics · doi:10.2307/2556164 · Cited by 761 · see citing works

Reduced Transit-Time Sensitivity in Noninvasive Magnetic Resonance Imaging of Human Cerebral Blood Flow

Alsop, D. C., & Detre, J. A. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199611000-00019 · Cited by 754 · see citing works

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

Gasparini, F., Lingenhöhl, K., Stoehr, N., Flor, P. J., Heinrich, M., Vranesic, I., Biollaz, M., Allgeier, H., Heckendorn, R., Urwyler, S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00082-9 · Cited by 725 · see citing works

Monoamine neurocircuitry in depression and strategies for new treatments

Hamon, M., & Blier, P. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.009 · Cited by 643 · see citing works

Cloning, Expression, and Gene Structure of a G Protein-Coupled Glutamate Receptor from Rat Brain

Houamed, K. M., Kuijper, J. L., Gilbert, T., Haldeman, B. A., O’Hara, P. J., Mulvihill, E. R., Almers, W., & Hagen, F. S. (1991) · Science · doi:10.1126/science.1656524 · Cited by 522 · see citing works

Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice

Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., Jaeschke, G., Bear, M. F., & Lindemann, L. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.009 · Cited by 489 · see citing works

Neurobiology of chronic mild stress: parallels to major depression

Hill, M. N., Hellemans, K. G. C., Verma, P., Gorzalka, B. B., & Weinberg, J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.001 · Cited by 420 · see citing works

Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond

Krystal, J. H., Sanacora, G., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.026 · Cited by 406 · see citing works

The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord

Dickenson, A. H., Chapman, V., & Green, G. M. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00359-x · Cited by 401 · see citing works

3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity

Cosford, N. D. P., Tehrani, L. R., Roppe, J. R., Schweiger, E. J., Smith, N. D., Anderson, J., Bristow, L. J., Brodkin, J. D., Jiang, X., McDonald, I. A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025570j · Cited by 397 · see citing works

Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1α, mGluR2 and mGluR5, relative to neurotransmitter release sites

Luján, R., Roberts, J. D. B., Shigemoto, R., Ohishi, H., & Somogyi, P. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)00051-3 · Cited by 395 · see citing works

Efficacy of Antidepressants as Analgesics: A Review

Dharmshaktu, P., Tayal, V., & Kalra, B. S. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010394852 · Cited by 326 · see citing works

Sleep EEG in the rat as a function of prior waking

Tobler, I., & Borbély, A. A. (1986) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(86)90044-1 · Cited by 319 · see citing works

The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain

Hunter, J. C., Gogas, K. R., Hedley, L. R., Jacobson, L. O., Kassotakis, L., Thompson, J., & Fontana, D. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00070-8 · Cited by 310 · see citing works

Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity

Porter, R. H. P., Jaeschke, G., Spooren, W., Ballard, T. M., Büttelmann, B., Kolczewski, S., Peters, J.-U., Prinssen, E., Wichmann, J., Vieira, E., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089839 · Cited by 308 · see citing works

Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins

Aronica, E., Gorter, J. A., Ijlst‐Keizers, H., Rozemüller, A. J. M., Yankaya, B., Leenstra, S., & Troost, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02657.x · Cited by 306 · see citing works

Antidepressants and their effect on sleep

Mayers, A., & Baldwin, D. (2005) · Human psychopharmacology · doi:10.1002/hup.726 · Cited by 305 · see citing works

Antidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine2C Receptors

Cryan, J. F., & Lucki, I. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39013-5 · Cited by 292 · see citing works

Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome

Krueger, D. D., & Bear, M. F. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-061109-134644 · Cited by 259 · see citing works

Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats

Moreau, J., Jenck, F., Martin, J. R., Mortas, P., & Haefely, W. E. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90035-7 · Cited by 250 · see citing works

Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia

Grippo, A. J., Francis, J., Beltz, T. G., Felder, R. B., & Johnson, A. K. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.02.011 · Cited by 233 · see citing works

NEUROBIOLOGY OF STRESS, DEPRESSION, AND RAPID ACTING ANTIDEPRESSANTS: REMODELING SYNAPTIC CONNECTIONS: Review: Remodeling Synaptic Connections

Duman, R. S. (2014) · Depression and Anxiety · doi:10.1002/da.22227 · Cited by 213 · see citing works

Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.

Ametamey, S. M., Kessler, L. J., Honer, M., Wyss, M. T., Buck, A., Hintermann, S., Auberson, Y. P., Gasparini, F., & Schubiger, P. A. (2006) · PubMed · Cited by 183 · see citing works

Enhanced Long-Term Synaptic Depression in an Animal Model of Depression

Holderbach, R., Clark, K., Moreau, J., Bischofberger, J., & Normann, C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.007 · Cited by 174 · see citing works

Central pathways controlling micturition and urinary continence

Blok, B. F. M. (2002) · Urology · doi:10.1016/s0090-4295(01)01633-8 · Cited by 170 · see citing works

Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.

Ametamey, S. M., Treyer, V., Streffer, J. R., Wyss, M. T., Schmidt, M. E., Blagoev, M., Hintermann, S., Auberson, Y. P., Gasparini, F., Fischer, U. C., et al. (2007) · PubMed · Cited by 166 · see citing works

Treatment of Anxiety Using Fenobam (a Nonbenzodiazepine) in a Double-Blind Standard (Diazepam) Placebo-Controlled Study

Pecknold, J. C., McClure, D., APPELTAUER, L., Wrzesinski, L., & ALLAN, T. (1982) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198204000-00010 · Cited by 165 · see citing works

Metabotropic Glutamate 5 Receptor Antagonism Is Associated with Antidepressant-Like Effects in Mice

Li, X., Need, A. B., Baez, M., & Witkin, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103143 · Cited by 163 · see citing works

The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

Busse, C. S., Brodkin, J. D., Tattersall, D., Anderson, J. J., Warren, N., Tehrani, L. R., Bristow, L. J., Varney, M. A., & Cosford, N. D. P. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300540 · Cited by 159 · see citing works

Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent

Higgins, G. A., Ballard, T. M., Kew, J. N. C., Richards, J. G., Kemp, J. A., Adam, G., Woltering, T. J., Nakanishi, S., & Mutel, V. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.018 · Cited by 158 · see citing works

Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

Hysek, C. M., Simmler, L. D., Nicola, V. G., Vischer, N., Donzelli, M., Krähenbühl, S., Grouzmann, E., Huwyler, J., Hoener, M. C., & Liechti, M. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036476 · Cited by 157 · see citing works

Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats

Pilc, A., Kłodzińska, A., Brański, P., Nowak, G., Pałucha-Poniewiera, A., Szewczyk, B., Tatarczynska, E., Chojnacka-Wójcik, E., & Wierońska, J. M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00082-5 · Cited by 150 · see citing works

Chronic mild stress-induced anhedonia model of depression

Moreau, J. ‐., Scherschlicht, R., Jenck, F., & Martin, J. R. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199511000-00003 · Cited by 144 · see citing works

AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study

Stocchi, F., Rascol, O., Destée, A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25561 · Cited by 138 · see citing works

Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608)

Spooren, W. P. J. M., Schoeffter, P., Gasparini, F., Kuhn, R., & Gentsch, C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01562-x · Cited by 137 · see citing works

5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats

Moreau, J., Bös, M., Jenck, F., Martin, J. R., Mortas, P., & Wichmann, J. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)00015-6 · Cited by 122 · see citing works

CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor

Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185660 · Cited by 118 · see citing works

Selective 5HT2A and 5HT6 Receptor Antagonists Promote Sleep in Rats

Morairty, S. R., Hedley, L. R., Flores, J., Martin, R. S., & Kilduff, T. S. (2008) · SLEEP · doi:10.1093/sleep/31.1.34 · Cited by 118 · see citing works

The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison

Ballard, T. M., Woolley, M. L., Prinssen, E. P. M., Huwyler, J., Porter, R., & Spooren, W. P. J. M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2211-9 · Cited by 110 · see citing works

Neuronal and immunological basis of action of antidepressants in chronic pain – clinical and experimental studies

Mika, J., Żychowska, M., Makuch, W., Rojewska, E., & Przewłocka, B. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71522-6 · Cited by 107 · see citing works

Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome

Scharf, S. H., Jaeschke, G., Wettstein, J. G., & Lindemann, L. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.11.004 · Cited by 106 · see citing works

From synapse to nucleus: Novel targets for treating depression

Covington, H. E., Vialou, V., & Nestler, E. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.004 · Cited by 98 · see citing works

Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target

Goeldner, C., Ballard, T. M., Knoflach, F., Wichmann, J., Gatti, S., & Umbricht, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.001 · Cited by 96 · see citing works

Preso1 dynamically regulates group I metabotropic glutamate receptors

Hu, J.-H., Yang, L., Kammermeier, P. J., Moore, C. G., Brakeman, P., Tu, J., Yu, S., Petralia, R. S., Li, Z., Zhang, P.-W., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3103 · Cited by 90 · see citing works

Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression

Hughes, Z. A., Neal, S. J., Smith, D. L., Rizzo, S. J. S., Pulicicchio, C. M., Lotarski, S. M., Lu, S.-P., Dwyer, J. M., Brennan, J. A., Olsen, M. A., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.007 · Cited by 85 · see citing works

Translational Concepts of mGluR5 in Synaptic Diseases of the Brain

Piers, T. M., Kim, D. H., Kim, B. C., Regan, P. L., Whitcomb, D. J., & Cho, K. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00199 · Cited by 76 · see citing works

Effects of cAMP-Phosphodiesterase Isozyme Inhibitor on Cytokine Production by Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells

Yoshimura, T., Kurita, C., Nagao, T., et al. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00580-0 · Cited by 74 · see citing works

ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies

Hintermann, S., Vranesic, I., Allgeier, H., Bruelisauer, A., Hoyer, D., Lemaire, M., Moenius, T., Urwyler, S., Whitebread, S., Gasparini, F., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.10.038 · Cited by 71 · see citing works

Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the monkey subthalamic nucleus

Kuwajima, M., Hall, R. A., Aiba, A., & Smith, Y. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20158 · Cited by 69 · see citing works

Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition

Marek, G. J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.058 · Cited by 67 · see citing works

Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice

Michalon, A., Bruns, A., Risterucci, C., Honer, M., Ballard, T. M., Ozmen, L., Jaeschke, G., Wettstein, J. G., von Kienlin, M., Künnecke, B., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.038 · Cited by 67 · see citing works

Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators: Discovery of 2-Chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1 <i>H</i> -imidazol-4-ylethynyl]pyridine (Basimglurant, RO4917523), a Promising Novel Medicine for Psychiatric Diseases

Jaeschke, G., Kolczewski, S., Spooren, W., Vieira, E., Bitter-Stoll, N., Boissin, P., Borroni, E., Büttelmann, B., Ceccarelli, S., Clemann, N., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501642c · Cited by 66 · see citing works

Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats

Rowley, H. L., Kulkarni, R. S., Gosden, J., Brammer, R. J., Hackett, D., & Heal, D. J. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113513850 · Cited by 65 · see citing works

Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model

Hsieh, M., Ho, S.-C., Yeh, K.-Y., Pawlak, C. R., Chang, H., Ho, Y., Lai, T.-J., & Wu, F.-Y. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.022 · Cited by 65 · see citing works

mGluR5 antagonists: discovery, characterization and drug development.

Gasparini, F., Bilbe, G., Gomez‐Mancilla, B., & Spooren, W. P. J. M. (2008) · PubMed · Cited by 64 · see citing works

Long-Term Memory Deficits are Associated with Elevated Synaptic ERK1/2 Activation and Reversed by mGluR5 Antagonism in an Animal Model of Autism

Seese, R. R., Maske, A. R., LYNCH, G. S., & Gall, C. M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.13 · Cited by 62 · see citing works

mGlu5 receptor antagonists and their therapeutic potential

Jaeschke, G., Wettstein, J. G., Nordquist, R. E., & Spooren, W. P. J. M. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.2.123 · Cited by 61 · see citing works

Characterization of the Antinociceptive Actions of Bicifadine in Models of Acute, Persistent, and Chronic Pain

Basile, A. S., Janowsky, A. J., Gołembiowska, K., Kowalska, M., Tam, E., Benveniste, M., Popik, P., Nikiforuk, A., Krawczyk, M., Nowak, G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116483 · Cited by 60 · see citing works

AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization

Vranesic, I., Ofner, S., Flor, P. J., Bilbe, G., Bouhelal, R., Enz, A., Desrayaud, S., McAllister, K., Kuhn, R., & Gasparini, F. (2014) · Bioorganic &amp; Medicinal Chemistry · doi:10.1016/j.bmc.2014.09.033 · Cited by 59 · see citing works

Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats

Bruns, A., Künnecke, B., Risterucci, C., Moreau, J., & von Kienlin, M. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21779 · Cited by 58 · see citing works

Chapter III Metabotropic glutamate receptors — immunocytochemical and in situ hybridization analyses

Shigemoto, R., & Mizuno, N. (2000) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(00)80044-5 · Cited by 57 · see citing works

Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine

Platt, D. M., Rowlett, J. K., & Spealman, R. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1191-y · Cited by 57 · see citing works

Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys

Spinelli, S., Ballard, T. M., Gatti‐McArthur, S., Richards, G. J., Kapps, M., Woltering, T. J., Wichmann, J., Stadler, H., Feldon, J., & Pryce, C. R. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2126-x · Cited by 57 · see citing works

Simulating the anhedonia symptom of depression in animals

Moreau, J. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.4/jlmoreau · Cited by 53 · see citing works

Differential effects of mGluR1 and mGlur5 antagonism on spatial learning in rats

Petersen, S., Bomme, C., Baastrup, C., Kemp, A., & Christoffersen, G. R. J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00829-8 · Cited by 43 · see citing works

Peripheral antinociceptive action of mangiferin in mouse models of experimental pain: Role of endogenous opioids, KATP-channels and adenosine

Lopes, S. C., da Silva, A. V. L., Arruda, B. R., Morais, T. C., Rios, J. B., Trevisan, M. T. S., Rao, V. S. N., & Santos, F. A. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.016 · Cited by 43 · see citing works

Influence of Glutamate Receptor Antagonists on Micturition in Rats with Spinal Cord Injury

Yoshiyama, M., Nezu, F. M., Yokoyama, O., et al. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7124 · Cited by 39 · see citing works

Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine produces antidepressant effects in rats: Role of brain-derived neurotrophic factor

Liu, C. Y., Jiang, X. X., Zhu, Y. H., & Wei, D. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.010 · Cited by 36 · see citing works

Mavoglurant as a treatment for Parkinson’s disease

Petrov, D., Pedrós, I., de Lemos, M. L., Pallàs, M., Canudas, A. M., Lazarowski, A., Beas‐Zárate, C., Auladell, C., Folch, J., & Camins, A. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.931370 · Cited by 36 · see citing works

Role of Spinal Glutamatergic Transmission in the Ascending Limb of the Micturition Reflex Pathway in the Rat

Κakizaki, H., Yoshiyama, M., Roppolo, J. R., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37366-5 · Cited by 36 · see citing works

Antidepressant Treatment in Anxiety Disorders

Bespalov, A., van Gaalen, M. M., & Groß, G. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_3 · Cited by 34 · see citing works

Neuroimaging and Physiological Evidence for Involvement of Glutamatergic Transmission in Regulation of the Striatal Dopaminergic System

Tokunaga, M., Seneca, N. M., Shin, R.-M., Maeda, J., Obayashi, S., Okauchi, T., Nagai, Y., Zhang, M., Nakao, R., Ito, H., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2559-08.2009 · Cited by 33 · see citing works

Metabotropic Glutamate Receptor 5 (mGluR5) Regulates Bladder Nociception

Crock, L. W., Stemler, K. M., Song, D., et al. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-20 · Cited by 33 · see citing works

Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats

Ahnaou, A., Langlois, X., Steckler, T., Bartolomé-Nebreda, J. M., & Drinkenburg, W. H. I. M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3746-4 · Cited by 32 · see citing works

Manifestations and functional implications of sleep homeostasis

Borbély, A. A., & Tobler, I. (2010) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52006-7.00013-7 · Cited by 32 · see citing works

Involvement of metabotropic glutamate receptor 5 in pudendal inhibition of nociceptive bladder activity in cats

Larson, J. A., Ogagan, P. D., Chen, G., et al. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.215657 · Cited by 31 · see citing works

Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 – present)

Célanire, S., Sebhat, I. K., Wichmann, J., Mayer, S., Schann, S., & Gatti, S. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.983899 · Cited by 28 · see citing works

The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain

Tronci, V., & Balfour, D. J. K. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.12.024 · Cited by 25 · see citing works

Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors

Harvey, B. D., Siok, C. J., Kiss, T., Volfson, D., Grimwood, S., Shaffer, C. L., & Hajós, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.020 · Cited by 21 · see citing works

The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception

Hu, Y., Dong, L., Sun, B., Guillon, M. A., Burbach, L. R., Nunn, P. A., Liu, X., Vilenski, O., Ford, A. P. D. W., Zhong, Y., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.026 · Cited by 21 · see citing works

Plasmid copy number and mutant frequencies in s. typhimurium ta102

Albertini, S., & Gocke, E. (1988) · Environmental Mutagenesis · doi:10.1002/em.2860120404 · Cited by 18 · see citing works

mGluR5 Antagonist-Induced Psychoactive Properties: MTEP Drug Discrimination, a Pharmacologically Selective Non–NMDA Effect with Apparent Lack of Reinforcing Properties

Swedberg, M. D. B., Ellgren, M., & Raboisson, P. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211185 · Cited by 18 · see citing works

Toward Neurotrophin-Based Therapeutics

Monteggia, L. M. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10111677 · Cited by 17 · see citing works

P.2.f.027 The efficacy and safety of basimglurant as adjunctive therapy in major depression; a randomised, double-blind, placebo-controlled study

Quiroz, J. A., Tamburri, P. A., Deptula, D., Banken, L., Beyer, U., da Fontoura, P. P., & Santarelli, L. (2014) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(14)70748-5 · Cited by 17 · see citing works

Interaction of group I mGlu and NMDA receptor agonists within the dorsal horn of the spinal cord of the juvenile rat

Dang, K., Naeem, S., Walker, K. M., Bowery, N. G., & Urbán, L. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704698 · Cited by 16 · see citing works

Comparison of different cytotoxicity measures for the in vitro micronucleus test (MNVit) in L5178Y tk+/− cells: Summary of 4 compounds (Mitomycin C, Cyclophosphamide, Colchicine and Diethylstilboestrol) with clastogenic and aneugenic mode of action

Kirchner, S., & Zeller, A. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.03.018 · Cited by 13 · see citing works

Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat

Cavas, M., Scesa, G., & Navarro, J. F. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.011 · Cited by 12 · see citing works

Preso1, mGluR5 and the machinery of pain

Radulović, J., & Tronson, N. C. (2012) · Nature Neuroscience · doi:10.1038/nn.3118 · Cited by 11 · see citing works

A pharmacokinetic–pharmacodynamic model for cardiovascular safety assessment of R1551

Fleury, A., Lavé, T., Jonsson, F., Schmitt, M., Hirkaler, G. M., Polonchuk, L., & Breidenbach, A. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.08.003 · Cited by 10 · see citing works

Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation.

Vallès, B., Schiller, C., Coassolo, P., et al. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06747-9 · Cited by 10 · see citing works

Structure-activity relationship of oxadiazoles and allylic structures in the Ames test: an industry screening approach

Muster, W. (2003) · Mutagenesis · doi:10.1093/mutage/geg006 · Cited by 9 · see citing works

Application of Modern Drug Metabolism Structure Determination Tools and Assays to the In Vitro Metabolism of Imiloxan

Fitch, W. L., Chen, Y., Liu, L., et al. (2010) · Drug Metabolism Letters · doi:10.2174/187231210791292753 · Cited by 8 · see citing works

Characterization of G-Protein Coupled Receptor Modulators Using Homogeneous cAMP Assays

Bassoni, D. L., Jafri, Q., Sastry, S., et al. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-909-9_8 · Cited by 6 · see citing works

The association between sleep disorders and depression: implications for treatment

Ahmadi, N., Saleh, P., & Shapiro, C. M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139042734.017 · Cited by 6 · see citing works

Long-term effects of antidepressants on sleep

Beitinger, M. E., & Fulda, S. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139042734.019 · Cited by 4 · see citing works

Transient mGlu5R inhibition enhances the survival of granule cell precursors in the neonatal cerebellum

Kubera, C., Hernandez, A. L., Heng, V., & Bordey, A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.064 · Cited by 4 · see citing works

Antidepressant-induced alteration of sleep EEG

Staner, L., Staner, C., & Luthringer, R. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139042734.020 · Cited by 2 · see citing works

Untitled work

Jones (1999) · doi:10.1002/(sici)1522-2594(199907)42:1

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome

Berry-Kravis, E. M., Lindemann, L., Jønch, A. E., Apostol, G., Bear, M. F., Carpenter, R. L., Crawley, J. N., Curie, A., Des Portes, V., Hossain, F., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.221 · Cited by 336 · see citing works

Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results

FragXis Study Group, Youssef, E. A., Berry-Kravis, E., Czech, C., Hagerman, R. J., Hessl, D., Wong, C. Y., Rabbia, M., Deptula, D., John, A., et al. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.177 · Cited by 133 · see citing works

Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial

Quiroz, J. A., Tamburri, P., Deptula, D., Banken, L., Beyer, U., Rabbia, M., Parkar, N., Fontoura, P., & Santarelli, L. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0838 · Cited by 133 · see citing works

New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity

Huang, Y.-J., Lane, H.-Y., & Lin, C.-H. (2017) · Neural Plasticity · doi:10.1155/2017/4605971 · Cited by 74 · see citing works

Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5

Fuxe, K., & Borroto-Escuela, D. O. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1074175 · Cited by 43 · see citing works

Population Pharmacokinetic and Exposure–dizziness Modeling for a Metabotropic Glutamate Receptor Subtype 5 Negative Allosteric Modulator in Major Depressive Disorder Patients

Cosson, V., Schaedeli‐Stark, F., Arab‐Alameddine, M., Chavanne, C., Guerini, E., Derks, M., & Mallalieu, N. L. (2018) · Clinical and Translational Science · doi:10.1111/cts.12566 · Cited by 7 · see citing works

Prolyl oligopeptidase alters cortical glutamate and function of metabotropic glutamate receptor mGluR5 in mice and in cells

Julku, U. H., Svarcbahs, R., & Myöhänen, T. T. (2018) · Proceedings for Annual Meeting of The Japanese Pharmacological Society · doi:10.1254/jpssuppl.wcp2018.0_po4-1-48

Anticonvulsant action of metabotropic glutamate receptor agonists in DBA/2 mice.

Horikawa, Y., Tamura, S., Inomata, N., et al. (1994) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)50445-0

Gene Expression of Metabotropic Glutamate Receptors Group II of Embryonic Rat Hippocampus Induced by Lead Exposure

Yu, X. (2003) · Acta Universitatis Medicinalis Secondae Shanghai

Neurophysiologic and Antipsychotic Profiles of TASP0433864, a Novel Positive Allosteric Modulator of Metabotropic Glutamate 2 Receptor

Hiyoshi, T., Marumo, T., Hikichi, H., Tomishima, Y., Urabe, H., Tamita, T., Iida, I., Yasuhara, A., Karasawa, J.-I., & Chaki, S. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218651 · Cited by 33 · see citing works

Dipyridyl amines: Potent metabotropic glutamate subtype 5 receptor antagonists

Kamenecka, T. M., Bonnefous, C., Govek, S. P., Vernier, J., Hutchinson, J. H., Chung, J., Reyes-Manalo, G., & Anderson, J. J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.06.059 · Cited by 8 · see citing works